Tudor Boloni, MBA
Tudor
Boloni, MBA is CEO at
Medical Biostasis.
Within five years Medical Biostasis plans on demonstrating that a set of
genomic pathway modulations, molecular additives, surgical protocols,
and off-the-shelf medical equipment, are sufficient to successfully
reanimate a human mind from a state of ageless biostasis. Such
ambitious timescales would not be possible without the modern tools of
genomic screens, carbon nanotechnology, and high-throughout molecule
discovery systems, riding the converging waves of deep hypothermic
surgical practices and 40 years of cryobiological
research.
Prior to launching Medical Biostasis, Tudor divided his time
between several life extension related projects. As the Director of
Systems Biology for the genomics company Genescient (owners of the
longest lived Drosophila colonies, selectively bred over 30 years for
maximum lifespan extension, and currently averaging over 400% longer
maximum lifetimes than wildtype controls), Tudor researched strategies
to discover the most sensitive parameters in the genetic pathways that
modulate the rate of aging.
As the former founder of a
neural-prosthetics research firm, Tudor still pursues his passion in
neuroscience with the study of normothermic brain perfusion systems and
the search for the neural correlates of consciousness. He has also
collaborated with the SENS Foundation to attempt to secure a sovereign
partner to sponsor a Manhattan Project scaled regenerative medicine
institute. He cofounded the investment bank BAC Romania, where he
was responsible for organizing the EUR 5 billion technology offset
program in the country’s fighter jet procurement program. He was
formerly a 25% partner in Maple Bank’s USD 500 million hedge fund for
mutual fund trading, and a former Senior Science Analyst for Cardinal
Fund Management (NY).
Tudor earned his MBA in Finance, International Business at
New York University — Leonard N. Stern School of Business in 1996.
He earned his CEMS Master’s in Economics at the London School of
Economics and Political Science in 1997.
Read his
LinkedIn profile.